-
Why Partnerships Are Crucial for Pushing Vaccine R&D Forward
Students in the Philippines began receiving doses of the world’s first dengue vaccine this week, as the country begins a public immunization program to inoculate 1 million children in 6,000 schools across the island nation.
- Categories
- Health Care
- Region
- South Asia
-
Pfizer May Leverage European Approval to Pneumonia Vaccine in Indian Market
New York-headquartered pharmaceutical giant Pfizer is likely to leverage its latest European approval for multi-dose vials of pneumococcal vaccine Prevnar 13 in the Indian market.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
High Global Vaccine Prices Could Worsen Angola’s Deadly Yellow Fever Outbreak
Angola is experiencing its worst yellow fever outbreak in 30 years, says the World Health Organization. The mosquito-borne disease was first reported in the capital Luanda in December last year. The disease has now infected more than 490 people and killed 198, says WHO.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Rotavirus Vaccine Developed Under Make in India Initiative
J P Nadda, Union Minister for Health and Family Welfare attended a function for the national launch of the Rotavirus vaccine as part of the Universal Immunisation Programme (UIP).
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
Pfizer Joins Human Vaccines Project
Pfizer said today it will join the Human Vaccines Project, a public–private consortium focused on speeding up development of vaccines and immunotherapies against major infectious diseases and cancers by decoding the human immune system.
- Categories
- Health Care
-
China Vows Crackdown on Fake Vaccines Amid Scandal
Chinese authorities have pledged to crack down on the black market sale of vaccines after a case was made public involving nearly $90 million (62 million pounds) worth of illegal vaccines that are suspected of being sold in dozens of provinces around the country.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
PATH Opens New Vaccine Innovation Center With $11M From Gates Foundation
PATH, the Seattle-based global heath nonprofit, is opening a new Center for Vaccine Innovation and Access, funded initially through an $11 million dollar grant from the Bill & Melinda Gates Foundation.
- Categories
- Health Care
-
Cancer Vaccines Move From ‘Far-fetched’ to Reality
The significant differences in cost of treatment versus vaccination make the HPV and hepatitis B vaccines highly cost effective in the developing world. And while there have been improvements in global vaccine coverage in the past decade, disparities still result from competing health priorities, limited resources, poor health systems, inadequate monitoring and supervision, among other things.
- Categories
- Health Care
- Tags
- vaccines
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.